3089.4000 -0.20 (-0.01%)
NSE Oct 30, 2025 15:31 PM
Volume: 94,609
 

Emkay
DLPL posted a robust quarter, with revenue growing 11% YoY on the back of
sample volume increasing 9% YoY and Swasthfit contributing 24% to the
topline.
Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended